Table 3

Operator and site factors versus the occurrence of an ischemic event (n=21)

All ischemic stroke or CITS
FactorNo of sites or operatorsNo of patientsPerforator stroke or CITS (n (%))n (%)p ValueDifference (95% CI)†
SAMMPRIS site enrollment
 High (≥12)1211110 (9.0)14 (12.6)0.185.7% (−2.7% to 14.3%)
 Low (<12)361025 (4.9)7 (6.9)
High enrolling registry site
 No381327 (5.3)11 (8.3)0.35−4.0% (−13.8% to 4.3%)
 Yes10818 (9.9)10 (12.3)
Primary specialty of interventionist
 Radiology391159 (7.8)10 (8.7)0.761: −2.4% (−15.6%  to 8.4%)
 Neurosurgery18724 (5.6)8 (11.1)2: −2.8% (−27.9%  to 10.3%)
 Neurology6262 (7.7)3 (11.5)3: −0.4% (−25.1%  to 15.5%)
Credentialing: No of study devices
 <1030713 (4.2)3 (4.2)0.054−8.5% (−15.94%  to 1.1%)
 ≥103314212 (8.5)18 (12.7)
Credentialing: No of aneurysm stents
 <62911611 (9.5)14 (12.1)0.264.9% (−3.9%  to 13.2%)
 ≥634974 (4.1)7 (7.2)
No of years in practice
 <8281046 (5.8)10 (9.6)0.99−0.5% (−8.9%  to 8.1%)
 ≥8351099 (8.3)11 (10.1)
No of SAMMPRIS PTAS cases
 <331432 (4.7)3 (7.0)0.58−3.6% (−11.5%  to 9.6%)
 ≥33217013 (7.6)18 (10.6)
  • *p Value for Fisher's exact test comparing percentages among groups.

  • †Difference between percentages, calculated as first group − second group, except for primary specialty (1: radiology − neurosurgery, 2: radiology − neurology, 3: neurosurgery − neurology).

  • ‡Total in both groups exceeds 63 interventionists because individual interventionists had patients in both groups.

  • CITS, cerebral infarct with temporary signs; PTAS, percutaneous transluminal angioplasty and stenting.